Modified proteases that inhibit complement activation

Details for Australian Patent Application No. 2011218753 (hide)

Owner Catalyst Biosciences, Inc.

Inventors Thanos, Christopher D.; Ruggles, Sandra Waugh; Nguyen, Jack; Madison, Edwin L.

Agent Spruson & Ferguson

Pub. Number AU-A-2011218753

Parent 2006304804

Filing date 2 September 2011

Wipo publication date 22 September 2011

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

15 September 2011 Complete Application Filed

22 September 2011 Application Open to Public Inspection

  Published as AU-A-2011218753

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218754-Methods and systems for presenting pari-mutuel betting options and constructing wagers

2011218752-Reproduction device, reproduction method, program, recording medium, and data structure